Effect of Oral Calcium Supplementation on Lipid Profile and Atherogenic Index of Plasma

Authors

  • Mya Thanda Sein University of Medicine 2 Yangon
  • Tint Swe Latt University of Medicine 2 Yangon
  • Ohnmar - University of Medicine 2 Yangon

Keywords:

calcium supplementation, lipid profile, atherogenic index of plasma (AIP)

Abstract

*Visual Abstracts prepared by Dr. Monica Therese Cating-Cabral

Objective. To assess the effect of oral calcium supplementation on lipid profile and atherogenic index of plasma (AIP). 

Methodology. This study was undertaken in 28 centrally obese male subjects [age 26.4 (6.5) years], BMI 31.6 (4.7) kg/m2, WC 99.4 (6.4) cm. All participants received six tablets of CaCO(250 mg of elemental calcium/ capsule, for a total of 1500 md/day) for 8 weeks. Serum lipid profile including triglyceride, total cholesterol, HDL-C, LDL- C was measured at baseline and after intervention. AIP was calculated by using formula = log (TG/HDL-C).

Results. Oral calcium supplementation achieved a 22% (36 mg/dL, p<0.001) reduction in Triglyceride  from baseline [163.4 (37.9) mg/dL] and 19.2% ( 5.8 mg/dL, p<0.001) increase in HDL-C from baseline [30.4 (7.4) mg/dL)]. There were no significant treatment effects on total cholesterol [217.1 (41.21) mg/dL vs 196.3 (46.2) mg/dL] and LDL-C [155.4 (45.1) mg/dL vs 136.3 (45.1) mg/dL]. Significant reduction in serum total cholesterol and LDL-C level was only found in dyslipidemic centrally obese subjects. AIP decreased significantly by 51% with calcium carbonate treatment [median and interquartile range; 0.35 (0.29-0.44) vs 0.17 (0.04-0.44), p<0.01].

Conclusion. Eight-week calcium supplementation at 1500 mg/day led to a significant change in lipid levels and AIP.

Downloads

Download data is not yet available.

Author Biographies

Mya Thanda Sein, University of Medicine 2 Yangon

Associate Professor

Department of Physiology

Tint Swe Latt, University of Medicine 2 Yangon

Rector

Ohnmar -, University of Medicine 2 Yangon

Professor and Head

Department of Physiology

References

Wu HY, Chen LL, Zheng J, Liao YF, Zhou M. Simple anthropometric indices in relation to cardiovascular risk factors in Chinese type 2 diabetic patients. Chin J Physiol. 2007;50(3):135-42.

Govers MJ, Van der Meet R. Effects of dietary calcium and phosphate on the intestinal interactions between calcium, phosphate, fatty acids, and bile acids. Gut. 1993;34:365–70.

http://dx.doi.org/10.1136/gut.34.3.365.

Mitchell WD, Fyfe T, Smith DA. The effect of oral calcium on cholesterol metabolism. J Atheroscler Res. 1968;8:913–22.

http://dx.doi.org/10.1016/S0368-1319(68)80005-5.

Jacqmain M, Doucet E, Després J, Bouchard C, Tremblay A. Calcium intake, body composition, and lipoprotein-lipid concentrations in adults. Am J Clin Nutr. 2003;77:1448–52.

Major GC, Alarie F, Doré J, Phouttama S, Trembl A. Supplementation with calcium and vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr.2007;85:54 –59.

Torres MR, Francischetti EA, Genelhu V, Sanjuliani AF. Effect of a high-calcium energy-reduced diet on abdominal obesity and cardiometabolic risk factors in obese Brazilian subjects. Int J Clin Pract. 2010; 64(8):1076-83.

http://dx.doi.org/10.1111/j.1742-1241.2009.02312.x.

Reid IR, Ames R, Mason B, et al. Effects of calcium supplementation on lipids, blood pressure, and body composition in healthy older men: a randomized controlled trial. Am J Clin Nutr. 2010;91: 131–9.

http://dx.doi.org/10.3945/ajcn.2009.28097.

Reid IR, Mason B, Horne A, et al. Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial. Am J Med. 2002; 112:343–7. http://dx.doi.org/10.1016/S0002-9343(01)01138-X.

Bell L, Halstenson CE, Halstenson CJ, Macres M, Keane WF. Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med. 1992;152:2441–4. http://dx.doi.org/10.1001/archinte.1992.00400240061010.

Denke MA, Fox MM, Schulte MC. Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men. J Nutr. 1993;123:1047–53.

Yacowitz H, Fleischman AI, Bierenbaum ML. Effects of oral calcium on serum lipids in man. BMJ. 1965;1:1352–4.

http://dx.doi.org/10.1136/bmj.1.5446.1352.

Carlson LA, Olsson AG, Oro L, Rossner S. Effects of oral calcium on serum cholesterol and triglycerides in patients with hyperlipidemia. Atherosclerosis 1971;14:391–400. http://dx.doi.org/10.1016/0021-9150(71)90067-0.

Shidfar F, Moghayedi M, Kerman SRJ, Hosseini S, Shidfar S. Effects of a calcium supplement on serum lipoproteins, apolipoprotein B, and blood pressure in overweight men. Int J Endocriol Metab. 2010;8(4):194–200.

Berg JM, Tymoczko JL, Stryer L. Biochemistry. 5th ed. WH, Freeman and company: New York, 2007.

Grover SA, Levington C, Panquest S. Identifying adults at low risk for significant hyperlipidemia: a validated clinical index. J.Clin.Epidemol.1999;52:49-55. http://dx.doi.org/10.1016/S0895-4356(98)00139-5.

Dobiasova M. Atherogenic index of plasma [log(triglyceride/HDL-C- Cholesterol)]:Theoretical and practical implications. Clin Chem. 2004; 1113–5.

Nwagha UI. Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria. Afr Health Sci. 2010; 10(3): 248–52.

Ceska R. Clinical implications of the metabolic syndrome. Diabetes Vasc. Dis Res. 2007;4(3):S2–S4.

Khazaál MS, (2013). Atherogenic Index of Plasma (AIP) as a parameter in predicting cardiovascular risk in males compared to the conventional dyslipidemic indices (cholesterol ratios). Karbala J. Med. 2013; 6(1): 1506-11.

Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013;127(1):2-4.

Sanchez M, de la Sierra A, Coca A, et al. (1997) Oral calcium supplementation reduces intraplatelet free calcium concentration and insulin resistance in essential hypertensive patients. Hypertension. 1997; 29: 531-6. http://dx.doi.org/10.1161/01.HYP.29.1.531.

Pikilidou MI , Lasaridis AN, Sarafidis PA, et al. Insulin sensitivity increase after calcium supplementation and change in intraplatelet calcium and sodium-hydrogen exchange in hypertensive patients with Type 2 diabetes. Diabetic Medicine. 2009; 26: 211-9.

http://dx.doi.org/10.1111/j.1464-5491.2009.02673.x.

Albrink MJ, Meigs JW. The relationship between serum triglycerides and skinfold thickness in obese subject. Ann NY Acad Sci. 1967;131:673–7.

Davidson P, Albrink MJ. Abnormal plasma insulin response with high plasma triglycerides independent of clinical diabetes or obesity. J Clin Invest. 1966;45:1000.

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18: 499–502.

Pottgen P, Davis ER: Why measure total calcium? Clin Chem. 1979;22: 1752–1753.

Sallis JF, Haskell WL, Wood PD, et al. Physical activity assessment methodology in the five-city project. Am J Epidemiol. 1985; 121 (1): 91–106.

Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: Institute of Medicine. 2010.

Hia'es TG, Jacobson NL, Beitz D C , Littledike ET. Dietary calcium and Vitamin D: risk factors in the development of atherosclerosis in young goats. J Nutr. 1985; 115: 167–78.

Hsu HH, Culley NC. Effects of dietary calcium on atherosclerosis, aortic calcification, and icterus in rabbits fed a supplemental cholesterol diet. Lipids Health Dis. 2006; 5:16.

http://dx.doi.org/10.1186/1476-511X-5-16.

Susanti E, Donosepoetro M, Patellong I, Arif M. Differences between several atherogenic parameters in patients with controlled and uncontrolled type 2 Diabetes Mellitus. Med J Indones. 2010; 19(2): 103–8. http://dx.doi.org/10.13181/mji.v19i2.392.

Monarca S, Zerbini I, Donato F. Drinking-water hardness and cardiovascular diseases: A review of epidemiological studies 1979-2004. World Health Organization August 2004.

Kynast-Gales S A, Massey L K. Effect of dietary calcium from dietary products on ambulatory blood pressure in hypertensive men. J American Diet Assoc. 1992; 92: 1497-501.

Levey WA, Manore MM, Vaughan LA, et al. Blood pressure response of white men with hypertension to two low-sodium metabolic diets with different levels of dietary calcium. J Am Diet Assoc. 1995; 95:1280-7. http://dx.doi.org/10.1016/S0002-8223(95)00337-1.

Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC. Regulation of adiposity by dietary calcium. FASEB J. 2000;14:1132–8.

Zemel MB. Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insulin resistance and hypertension. Mol Cell Biochem. 1998;188:129–36.

http://dx.doi.org/10.1023/A:1006880708475.

Shi H, Halvorsen YD, Ellis PN, Wilkison WO, Zemel MB. Role of intracellular calcium in human adipocyte differentiation. Physiol Genomics. 2000;3:75–82.

Michaud EJ, Mynatt RL, Miltenberger RJ, et al. Role of the agouti gene in obesity. J Endocrinol. 1997;155:207–9.

http://dx.doi.org/10.1677/joe.0.1550207.

Saunders D, Sillery J, Chapman R. Effect of calcium carbonate and aluminum hydroxide on human intestinal function. Dig Dis Sci. 1988; 33: 408–13. http://dx.doi.org/10.1007/BF01536023.

Published

2014-11-29

How to Cite

Sein, M. T., Latt, T. S., & -, O. (2014). Effect of Oral Calcium Supplementation on Lipid Profile and Atherogenic Index of Plasma. Journal of the ASEAN Federation of Endocrine Societies, 29(2), 135. Retrieved from https://asean-endocrinejournal.org/index.php/JAFES/article/view/128

Issue

Section

Original Articles

Most read articles by the same author(s)